about
A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemiaEzetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic groupMechanisms and assessment of statin-related muscular adverse effects.Treating statin-intolerant patientsRosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia.The SLCO1B1*5 genetic variant is associated with statin-induced side effects.Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.Management of statin intoleranceGenetics and personalized medicine--a role in statin therapy?Terminalia arjuna improves cardiovascular autonomic neuropathy in streptozotocin-induced diabetic rats.Improvement in myocardial function by Terminalia arjuna in streptozotocin-induced diabetic rats: possible mechanisms.Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.Laparoscopic partial nephrectomy in a patient on simvastatin : Delayed recovery from neuromuscular blockade.Red yeast rice prevents atherosclerosis through regulating inflammatory signaling pathways.Pharmacokinetics and safety of ezetimibe/simvastatin combination tablet: an open-label, single-dose study in healthy Chinese subjects.
P2860
Q33711391-003D5274-DDF9-4739-A846-C22B951BB10DQ33921592-6E41BC7A-C958-4E63-A846-34855116616CQ34047278-B906477A-46FD-4887-9F38-93735CB4A1C2Q34570995-5483660E-8EA7-49B3-9756-CB85D4EC9CB2Q35110510-7A832BDC-9AE7-4C92-98A9-DEA131D1ADE8Q36139098-67BA4D95-0B23-49C0-9E4E-BA961801841EQ36158024-80DFB997-2E58-4090-84E3-D2C7C8EB9823Q36674896-488E9C28-3A7F-4140-9FA5-C270672B457FQ37414000-BE35A58B-7518-4E4A-B9B3-419A5D44E07EQ38167710-A60C03FB-BF52-4F1B-A4D9-8B30D18A8936Q43726077-F0F145E1-AAAF-4859-97AD-4D8777E3EE9AQ44702438-DB715F0D-04A0-4507-AC0B-D416FD348828Q46745025-34F3743E-82F0-401A-B7F7-5F510227DBF1Q47323020-9516F72F-C3C7-4CB5-8E0F-A02B5D465936Q47871314-5F423645-D04A-4E45-89D2-290F22055824Q51299977-CC7ECC6B-5237-4044-B57A-9FDA02061144
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Statins, cardiovascular disease, and drug safety.
@ast
Statins, cardiovascular disease, and drug safety.
@en
type
label
Statins, cardiovascular disease, and drug safety.
@ast
Statins, cardiovascular disease, and drug safety.
@en
prefLabel
Statins, cardiovascular disease, and drug safety.
@ast
Statins, cardiovascular disease, and drug safety.
@en
P1476
Statins, cardiovascular disease, and drug safety.
@en
P2093
Antonio M Gotto
P356
10.1016/J.AMJCARD.2005.12.005
P407
P577
2006-01-25T00:00:00Z